These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 2653923)
1. Nootropics and metabolically active compounds in Alzheimer's disease. Nicholson CD Biochem Soc Trans; 1989 Feb; 17(1):83-5. PubMed ID: 2653923 [No Abstract] [Full Text] [Related]
2. Glial modulating and neurotrophic properties of propentofylline and its application to Alzheimer's disease and vascular dementia. Ringheim GE Ann N Y Acad Sci; 2000 Apr; 903():529-34. PubMed ID: 10818548 [No Abstract] [Full Text] [Related]
3. Nootropics: preclinical results in the light of clinical effects; comparison with tacrine. Mondadori C Crit Rev Neurobiol; 1996; 10(3-4):357-70. PubMed ID: 8978986 [TBL] [Abstract][Full Text] [Related]
9. Pharmacology of nootropics and metabolically active compounds in relation to their use in dementia. Nicholson CD Psychopharmacology (Berl); 1990; 101(2):147-59. PubMed ID: 2190256 [TBL] [Abstract][Full Text] [Related]
10. Can the pattern of neuropsychological improvement obtained with cholinergic drugs be used to infer a cholinergic mechanism in other nootropic drugs? Gainotti G; Nocentini U; Sena E Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13 Suppl():S47-59. PubMed ID: 2694229 [TBL] [Abstract][Full Text] [Related]
11. The effects of nootropics on memory: new aspects for basic research. Mondadori C; Petschke F; Häusler A Pharmacopsychiatry; 1989 Oct; 22 Suppl 2():102-6. PubMed ID: 2690149 [TBL] [Abstract][Full Text] [Related]
12. Involvement of a steroidal component in the mechanism of action of piracetam-like nootropics. Mondadori C; Bhatnagar A; Borkowski J; Häusler A Brain Res; 1990 Jan; 506(1):101-8. PubMed ID: 2137359 [TBL] [Abstract][Full Text] [Related]
13. Alzheimer's disease. Is it worth treating? Hollister LE Drugs; 1985 Jun; 29(6):483-8. PubMed ID: 4006773 [No Abstract] [Full Text] [Related]
14. The pharmacology of the nootropics; new insights and new questions. Mondadori C Behav Brain Res; 1993 Dec; 59(1-2):1-9. PubMed ID: 8155275 [TBL] [Abstract][Full Text] [Related]
15. [Effects of amiridin and tacrine, drugs effective in Alzheimer's disease, on the activity of monoamine oxidase A and B]. Burov IuV; Baĭmanov TD; Tat'ianenko LV; Sokolova NM; Tereshchenkova IM Biull Eksp Biol Med; 1992 Feb; 113(2):149-50. PubMed ID: 1611059 [TBL] [Abstract][Full Text] [Related]
16. Elevated corticosteroid levels block the memory-improving effects of nootropics and cholinomimetics. Mondadori C; Ducret T; Häusler A Psychopharmacology (Berl); 1992; 108(1-2):11-5. PubMed ID: 1410129 [TBL] [Abstract][Full Text] [Related]
17. Modulation of the effects on learning and memory of nootropic drugs and central stimulants when applied together. Petkov VD; Konstantinova E; Petkov VV; Lazarova M; Petkova B Acta Physiol Pharmacol Bulg; 1991; 17(4):17-26. PubMed ID: 1688150 [TBL] [Abstract][Full Text] [Related]
18. Influence of nootropic drugs on the learning- and memory-impairing effect of diethyldithiocarbamate in albino rats. Genkova MG; Lazarova MB Methods Find Exp Clin Pharmacol; 1988 Jun; 10(6):369-75. PubMed ID: 2842556 [TBL] [Abstract][Full Text] [Related]